Skip to content
ScienceDirrect

Journal of Taibah University Medical Sciences

Date: 16 September 2026

Volume 21, Issue 5 · Pages: 1061–1070

Show more⌄
Original Article● Open accessUnder a Creative Commons license ↗
Original Article

Fundus autofluorescence as a marker of atrophic changes in ABCA4-associated Stargardt disease

Show more⌄

Abstract

ObjectiveTo examine the value and limitations of fundus autofluorescence (FAF) for measuring atrophic change in ABCA4-associated Stargardt disease, with particular attention to lesion definitions, longitudinal interpretation and structural–functional correspondence.Materials and methodsA focused narrative review of primary human studies was undertaken using targeted searches of web-accessible bibliographic and full-text sources. Longitudinal ProgStar reports, multimodal imaging studies…

Keywords
ABCA4; Stargardt disease; fundus autofluorescence; macular atrophy; optical coherence tomography; quantitative autofluorescence

Authors and affiliations

Nurullo Khait ugli Sadullaev, Sherzod Rakhmatovich Abdullaev

Author affiliations are listed in the full article PDF.

Objective

To examine the value and limitations of fundus autofluorescence (FAF) for measuring atrophic change in ABCA4-associated Stargardt disease, with particular attention to lesion definitions, longitudinal interpretation and structural–functional correspondence.

Materials and methods

A focused narrative review of primary human studies was undertaken using targeted searches of web-accessible bibliographic and full-text sources. Longitudinal ProgStar reports, multimodal imaging studies and reproducibility investigations were considered separately. Published aggregate values were used for the figures. No new clinical cohort, pooled estimate or patient-level correlation was generated.

Results

Definitely decreased autofluorescence (DDAF) provides a measurable marker of advanced tissue damage, but it is not interchangeable with questionably decreased autofluorescence or calibrated signal intensity. In the 24-month ProgStar analysis, annual DDAF enlargement was 0.74 mm², with a 95% confidence interval of 0.64–0.85 mm². Baseline lesion size influenced enlargement. Multimodal studies identified abnormalities beyond the darkest FAF core, while multicentre quantitative FAF measurements retained appreciable test–retest variability.

Conclusion

FAF is useful for documenting the extent and progression of atrophic lesions when acquisition and grading remain consistent. Its interpretation is strongest when lesion area is considered together with foveal topography, OCT evidence of outer retinal damage and a separate functional assessment.

Full article

Open the full article PDF

How to cite

Nurullo Khait ugli Sadullaev, Sherzod Rakhmatovich Abdullaev. (2026). Fundus autofluorescence as a marker of atrophic changes in ABCA4-associated Stargardt disease. Journal of Taibah University Medical Sciences, Volume 21, Issue 5, 1061–1070. Article ID: SDR-2026-0011.

All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
RELX